Newsletter | Venue | Contact

Conference and Matchmaking Location: Konzil Konstanz*
Conference Language: English

Day 1, October 12, 2022

Programme October 12, 2022

10.00

Pre-conference event:
Matchmaking with organized 1-to-1 meetings (only a limited number of tickets available!)

12.30

Registration, exhibition & networking

14.00

Welcome and introduction by BioLAGO

Session 1: The diagnostic laboratory in 2032 - reflecting medical needs in changing health systems

Chair: Dr. Simone Günther, Becton Dickinson (D/US)

14.10

Keynote
A vision of data ecosystem for future diagnostics
Dr. Razvan Ionasec, Amazon Web Services

14.35

Vision Statements: The diagnostic laboratory in 2032
- Cancer perspective: Dr. Simone Günther, Becton Dickinson (D/US)
- Microbiology view: Dr. Oliver Nolte, Center for Laboratory Medicine St. Gallen (CH)
- Diabetes & cardiovascular perspective: Prof. Dr. Andreas Nüssler / Dr. med. Sabrina Ehnert, BG Clinics (D)

15.05

Molecular tumor boards in decentral settings
Prof. Dr. med. Uwe Martens, SLK Clinics Heilbronn / MOLIT Institute (D)

15.25

Plenary discussion

15.35

Coffee break, exhibition & networking

Session 2: Detecting resistance on various levels

Chair: Dr. Michael Steinwand, BioLAGO

16.15

Novel trends for antimicrobial susceptibility testing (AST) of bacterial infection
Prof. Dr. Hans-Peter Deigner, HFU Furtwangen University (D)

16.40

Fully automated quantification of relevant antibiotics - an option for timely Therapeutical Drug Monitoring (TDM) in critically ill patients?
Dr. Matthias Herkert, DRG Instruments GmbH (D) and PD Dr. med. Johannes Zander, Laboratory Dr. Brunner (D)

17.00

Topic: Detecting resistance from the laboratory view
N.N.

17.20

Plenary discussion

17.30

Networking and exhibition

18.00

Conference Dinner

Day 2, October 13, 2022

Programme October 13, 2022

08.00

Registration, exhibition & networking

09.00

Introduction and review of Day 1:
Dr. Michael Steinwand, BioLAGO (D)

Session 3: Cancer & Co. - diagnostics for complex diseases

Chair: Marc Masa, LEITAT Technological Center (ESP)

09.05

Keynote
Orphan diseases: Diagnosis of Hemophagocytic Lymphohistiocytosis (HLH)
Prof. Dr. med. Paul Graf La Rosée, Schwarzwald-Baar Clinics (D)
Dr. Martin Ritthaler, Center for Human Genetics Tuebingen (D)

09.30

Precision medicine for individual cancer immunotherapy
Dr. Marcus Dühren-von Minden, AVA Life Science GmbH (D)

09.50

The importance of determining T-Cell response in vaccinated individuals - overview on an optimized protocol, current practice and future trends beyond Sars-Cov-2
Dr. Gianluca Rotta, BD Biosciences (IT)

10.10

Using single cell analyses for clinical-decision making and their future role in routine diagnostic applications
Dr. Guilhem Tourniaire, Cellenion (F)

10.30

Plenary discussion

10.40

Networking & exhibition

Session 4: AI & Digital diagnostics with focus on prevalent diseases

Chair: Prof. Dr. Klazine van der Horst, Bern University of Applied Sciences (CH)

11.15

Keynote
Concepts for therapeutical home monitoring
Prof. Dr. med. Christiane Brockes, alcare AG (CH)

11.40

Covid-19 infection: rapid detection via wearables
Kirsten Grossmann-von Haugwitz, Dr. Risch (LI/CH)

12:00

Bridging the gap between routine diagnostics and -omics data: implementation of AI assisted decision making
Jan Kirchhoff, medicalvalues GmbH (D)

12.20

Topic: Digital pathology and AI for cancer screening
Prof. Dr. John O'Leary, Trinity College Dublin (IRL)

12.40

Plenary discussion

12.50

Conference lunch & exhibition

Session 5: Pitching topics from the white board (interactive session)!

Chair: Prof. Dr. David Drissner, Albstadt-Sigmaringen University (D) / BioLAGO

14.15

Pitch presentations - voted by the attendees
Post your ideas for better diagnostics. Voted by the attendees, the 5 most brilliant contributions get the chance for a pitch presentation on stage.
Whether graduate, researcher, start-up or experienced company - everyone can take part. More information.

15:30

Closing remarks and networking apéro

*The Conference will take place physically ensuring a safe participation during the coronavirus pandemic. For more information, please see our full Hygiene and Safety Measures.